News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
716,039 Results
Type
Article (40889)
Company Profile (293)
Press Release (674849)
Multimedia
Podcasts (79)
Webinars (17)
Section
Business (205437)
Career Advice (2030)
Deals (35600)
Drug Delivery (101)
Drug Development (81460)
Employer Resources (173)
FDA (16350)
Job Trends (14977)
News (347263)
Policy (32800)
Tag
Academia (2578)
Accelerated approval (15)
Adcomms (24)
Allergies (115)
Alliances (49921)
ALS (134)
Alzheimer's disease (1563)
Antibody-drug conjugate (ADC) (220)
Approvals (16450)
Artificial intelligence (398)
Autoimmune disease (78)
Automation (29)
Bankruptcy (364)
Best Places to Work (11659)
BIOSECURE Act (21)
Biosimilars (149)
Biotechnology (190)
Bladder cancer (131)
Brain cancer (45)
Breast cancer (484)
Cancer (3810)
Cardiovascular disease (308)
Career advice (1709)
Career pathing (33)
CAR-T (227)
CDC (43)
Cell therapy (611)
Cervical cancer (31)
Clinical research (68307)
Collaboration (1315)
Company closure (4)
Compensation (913)
Complete response letters (43)
COVID-19 (2695)
CRISPR (72)
C-suite (566)
Cystic fibrosis (131)
Data (4597)
Decentralized trials (2)
Denatured (27)
Depression (95)
Diabetes (421)
Diagnostics (6561)
Digital health (33)
Diversity (11)
Diversity, equity & inclusion (45)
Drug discovery (186)
Drug pricing (158)
Drug shortages (28)
Duchenne muscular dystrophy (192)
Earnings (88977)
Editorial (45)
Employer branding (21)
Employer resources (151)
Events (115880)
Executive appointments (932)
FDA (18779)
Fibrodysplasia Ossificans Progressiva (4)
Friedreich's ataxia (6)
Frontotemporal dementia (15)
Funding (1194)
Gene editing (159)
Generative AI (31)
Gene therapy (481)
GLP-1 (869)
Government (4619)
Grass and pollen (5)
Guidances (359)
Healthcare (18877)
HIV (42)
Huntington's disease (37)
IgA nephropathy (59)
Immunology and inflammation (207)
Immuno-oncology (17)
Indications (54)
Infectious disease (2919)
Inflammatory bowel disease (177)
Inflation Reduction Act (15)
Influenza (93)
Intellectual property (187)
Interviews (315)
IPO (16643)
IRA (50)
Job creations (3675)
Job search strategy (1438)
Kidney cancer (15)
Labor market (72)
Layoffs (540)
Leadership (27)
Legal (7974)
Liver cancer (85)
Longevity (11)
Lung cancer (546)
Lymphoma (260)
Machine learning (29)
Management (59)
Manufacturing (584)
MASH (134)
Medical device (13631)
Medtech (13654)
Mergers & acquisitions (19833)
Metabolic disorders (1035)
Multiple sclerosis (132)
NASH (16)
Neurodegenerative disease (201)
Neuropsychiatric disorders (50)
Neuroscience (2520)
NextGen: Class of 2025 (6555)
Non-profit (4505)
Now hiring (58)
Obesity (483)
Opinion (243)
Ovarian cancer (135)
Pain (153)
Pancreatic cancer (170)
Parkinson's disease (226)
Partnered (27)
Patents (403)
Patient recruitment (315)
Peanut (52)
People (58580)
Pharmaceutical (67)
Pharmacy benefit managers (24)
Phase I (21283)
Phase II (30069)
Phase III (22407)
Pipeline (2701)
Policy (247)
Postmarket research (2565)
Preclinical (9075)
Press Release (64)
Prostate cancer (191)
Psychedelics (42)
Radiopharmaceuticals (256)
Rare diseases (605)
Real estate (5982)
Recruiting (69)
Regulatory (23550)
Reports (51)
Research institute (2361)
Resumes & cover letters (352)
Rett syndrome (15)
RNA editing (14)
RSV (67)
Schizophrenia (125)
Series A (200)
Series B (149)
Service/supplier (13)
Sickle cell disease (74)
Special edition (20)
Spinal muscular atrophy (149)
Sponsored (35)
Startups (3659)
State (2)
Stomach cancer (14)
Supply chain (93)
Tariffs (80)
The Weekly (50)
Vaccines (909)
Venture capital (65)
Weight loss (315)
Women's health (55)
Worklife (17)
Date
Today (145)
Last 7 days (648)
Last 30 days (2622)
Last 365 days (30742)
2025 (25041)
2024 (35331)
2023 (40181)
2022 (51291)
2021 (55838)
2020 (54157)
2019 (46643)
2018 (35125)
2017 (32223)
2016 (31634)
2015 (37708)
2014 (31456)
2013 (26499)
2012 (28771)
2011 (29427)
2010 (27525)
Location
Africa (731)
Alabama (71)
Alaska (7)
Arizona (270)
Arkansas (13)
Asia (38886)
Australia (6367)
California (9279)
Canada (2828)
China (851)
Colorado (389)
Connecticut (396)
Delaware (260)
Europe (83815)
Florida (1382)
Georgia (299)
Hawaii (2)
Idaho (61)
Illinois (715)
India (48)
Indiana (450)
Iowa (18)
Japan (316)
Kansas (120)
Kentucky (34)
Louisiana (18)
Maine (68)
Maryland (1207)
Massachusetts (6760)
Michigan (282)
Minnesota (536)
Mississippi (4)
Missouri (110)
Montana (29)
Nebraska (25)
Nevada (103)
New Hampshire (73)
New Jersey (2549)
New Mexico (28)
New York (2508)
North Carolina (1252)
North Dakota (8)
Northern California (4317)
Ohio (283)
Oklahoma (20)
Oregon (38)
Pennsylvania (1945)
Puerto Rico (18)
Rhode Island (43)
South America (1102)
South Carolina (48)
South Dakota (1)
Southern California (3567)
Tennessee (148)
Texas (1439)
United States (33585)
Utah (272)
Virginia (221)
Washington D.C. (78)
Washington State (772)
West Virginia (4)
Wisconsin (78)
Wyoming (1)
716,039 Results for "nascent biosciences inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Cellectar Biosciences, Inc. Enters Into Agreements to Raise $5.8 Million
October 8, 2025
·
5 min read
Business
Nascent Biotech and Manhattan BioSolutions Collaborate to Explore Pritumumab Antibody-Drug Conjugates
Nascent Biotech, Inc. (OTCQB:NBIO) (“Nascent Biotech”, “Nascent”), announced today it has entered into a research collaboration agreement with Manhattan BioSolutions, Inc. (Manhattan Bio), an emerging biotech company focused on precision biologics, to explore antibody-drug conjugates (ADCs) using Nascent’s lead clinical candidate pritumumab (PTB) as the tumor-targeting antibody element.
February 6, 2024
·
4 min read
Business
Nascent Collaborates With Hypospray Pharma on Proprietary Transdermal Delivery System
Nascent Biotech, Inc. and HypoSpray Pharma announced today a collaboration to develop an alternative delivery mechanism for patients who can benefit from Pritumumab.
March 19, 2024
·
4 min read
Drug Development
Nascent Prepares for Pivotal Phase II Research with Fresh Manufacturing Run
Nascent Biotech, Inc. announces that it is embarking on a fresh manufacturing run to ensure Pritumumab supplies are at maximum potency when patient dosing begins in the upcoming Phase II clinical trial.
April 16, 2024
·
3 min read
Press Releases
Xenetic Biosciences, Inc. Announces Pricing of $4.5 Million Underwritten Offering of Common Stock
October 13, 2025
·
4 min read
Press Releases
Forte Biosciences, Inc. Reports Inducement Grants Under Nasdaq Listing Rules - October 3, 2025
October 5, 2025
·
1 min read
Press Releases
Revelation Biosciences Inc. Announces Exercise of Warrants for $9.6 Million in Gross Proceeds
September 12, 2025
·
5 min read
Press Releases
Forte Biosciences, Inc. Announces Results and Provides Update 2025
August 15, 2025
·
8 min read
Press Releases
Nascent Biotech Receives Delinquency Notification Related to its Delayed September 30, 2024 Financial Filing
January 21, 2025
·
2 min read
Nascent Biotech Completes Payment of Variable Convertible Note in Full to Eliminate Dilution Risk
Nascent Biotech, Inc. is pleased to announce that the Company has completed payment of all outstanding variable convertible debt obligations.
December 19, 2023
·
2 min read
1 of 71,604
Next
